Effect of a New Potent Acid Inhibitory Drug, Vonoprazan on Healing Rate of Peptic Ulcers
Not Applicable
- Conditions
- Peptic Ulcers
- Registration Number
- JPRN-UMIN000030384
- Lead Sponsor
- Department of Gastroenterology, Akita University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
inpatient with another disease a patient with the disease which has the risk of peptic ulcer a patient who underwent GI tract operation before malignant ulcer ulcers located at duodenal 2nd portion a patient who were administrated vonoprazan 20mg before
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to check the healing status of the peptic ulcers (gastric ulcer, 8 weeks after / duodenal ulcer, 6 weeks after)
- Secondary Outcome Measures
Name Time Method